Approval · Notice of Compliance 9359 · 2008
FLUCONAZOLE INJECTION: Notice of Compliance 9359
Issued February 11, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9359
- Date
- February 11, 2008
- Company
- Pharmaceutical Partners Of Canada IncRichmond Hill, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antifungal agent
- Canadian reference product
- DIFLUCAN INJECTION (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUCONAZOLE INJECTION | 02248731 | Cancelled Pre Market |
Medicinal ingredients
- FLUCONAZOLE 2 MG per ML